Inflammation in Benign Prostate Tissue and Prostate Cancer in the Finasteride Arm of the Prostate Cancer Prevention Trial


Murtola T. J. , GÜREL B. , Umbehr M., Lucia M. S. , Thompson I. M. , Goodman P. J. , ...Daha Fazla

CANCER EPIDEMIOLOGY BIOMARKERS & PREVENTION, cilt.25, ss.463-469, 2016 (SCI İndekslerine Giren Dergi) identifier identifier identifier

  • Cilt numarası: 25 Konu: 3
  • Basım Tarihi: 2016
  • Doi Numarası: 10.1158/1055-9965.epi-15-0987
  • Dergi Adı: CANCER EPIDEMIOLOGY BIOMARKERS & PREVENTION
  • Sayfa Sayıları: ss.463-469

Özet

Background: A previous analysis of the placebo arm of the Prostate Cancer Prevention Trial (PCPT) reported 82% overall prevalence of intraprostatic inflammation and identified a link between inflammation and higher-grade prostate cancer and serum PSA. Here, we studied these associations in the PCPT finasteride arm.